German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus

von der Schulenburg J-MG, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mittendorf T, Rebscher H, Schoeffski O, Vauth C, Volmer T, et al. (2008)
VALUE IN HEALTH 11(4): 539-544.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Publishing Year
ISSN
PUB-ID

Cite this

von der Schulenburg J-MG, Greiner W, Jost F, et al. German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH. 2008;11(4):539-544.
von der Schulenburg, J. - M. G., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., et al. (2008). German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH, 11(4), 539-544. doi:10.1111/j.1524-4733.2007.00301.x
von der Schulenburg, J. - M. G., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., Rebscher, H., Schoeffski, O., Vauth, C., et al. (2008). German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH 11, 539-544.
von der Schulenburg, J.-M.G., et al., 2008. German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH, 11(4), p 539-544.
J.-M.G. von der Schulenburg, et al., “German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus”, VALUE IN HEALTH, vol. 11, 2008, pp. 539-544.
von der Schulenburg, J.-M.G., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., Rebscher, H., Schoeffski, O., Vauth, C., Volmer, T., Wahler, S., Wasem, J., Weber, C.: German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH. 11, 539-544 (2008).
von der Schulenburg, J. -Matthias Graf, Greiner, Wolfgang, Jost, Fred, Klusen, Norbert, Kubin, Maria, Leidl, Reiner, Mittendorf, Thomas, Rebscher, Herbert, Schoeffski, Oliver, Vauth, Christoph, Volmer, Timm, Wahler, Steffen, Wasem, Juergen, and Weber, Christian. “German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus”. VALUE IN HEALTH 11.4 (2008): 539-544.
This data publication is cited in the following publications:
This publication cites the following data publications:

66 Citations in Europe PMC

Data provided by Europe PubMed Central.

Practical issues in handling data input and uncertainty in a budget impact analysis.
Nuijten MJ, Mittendorf T, Persson U., Eur J Health Econ 12(3), 2011
PMID: 20364289
Health burden and costs of obesity and overweight in Germany.
Konnopka A, Bödemann M, König HH., Eur J Health Econ 12(4), 2011
PMID: 20401679
Cost of low back pain in Switzerland in 2005.
Wieser S, Horisberger B, Schmidhauser S, Eisenring C, Brügger U, Ruckstuhl A, Dietrich J, Mannion AF, Elfering A, Tamcan O, Müller U., Eur J Health Econ 12(5), 2011
PMID: 20526649
Nutrition economics - characterising the economic and health impact of nutrition.
Lenoir-Wijnkoop I, Dapoigny M, Dubois D, van Ganse E, Gutiérrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley MJ, Salminen S, Nuijten MJ., Br J Nutr 105(1), 2011
PMID: 20797310
Health care costs and their predictors of inflammatory bowel diseases in Germany.
Prenzler A, Bokemeyer B, von der Schulenburg JM, Mittendorf T., Eur J Health Econ 12(3), 2011
PMID: 20967482
Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany.
Neilson AR, Sieper J, Deeg M., Rheumatology (Oxford) 49(11), 2010
PMID: 20660498
General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals.
Goeree R, O'Reilly D, Hopkins R, Blackhouse G, Tarride JE, Xie F, Lim M., Expert Rev Pharmacoecon Outcomes Res 10(4), 2010
PMID: 20715915
Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men.
Haring R, Baumeister SE, Völzke H, Kohlmann T, Marschall P, Flessa S, Nauck M, Wallaschofski H., Int J Androl 33(6), 2010
PMID: 20059581
Methods of economic evaluation for the German statutory healthcare system.
Mittendorf T, Greiner W, von der Schulenburg JM., Pharmacoeconomics 27(3), 2009
PMID: 19354346
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.
Mittendorf T, Smith-Palmer J, Timlin L, Happich M, Goodall G., Diabetes Obes Metab 11(11), 2009
PMID: 19732121
Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany.
Braun S, Mittendorf T, Menschik T, Greiner W, von der Schulenburg JM., Breast Care (Basel) 4(6), 2009
PMID: 20877674

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 18194408
PubMed | Europe PMC

Search this title in

Google Scholar